InvestorsHub Logo

blue_skies

05/04/20 2:28 PM

#220 RE: JohnCM #219

ugly day right out of the gate. I see an overbought stock after a nice run up. Not a lot of room for disappointment in earnings. Cautious(fearful) investors taking money off the table. A cycle that looks like it is feeding on itself.

The following chart screams overbought! Possible support at the $10 level? Who knows?

https://stockcharts.com/h-sc/ui?s=krmd



These are just my thoughts - make your own investment decisions!!

blue_skies

05/04/20 2:40 PM

#221 RE: JohnCM #219

The fundamentals of Koru medical story remain positive. The covid-19 pandemic strengthened the argument for home subcutaneous immunoglobulin infusion. It is cheaper, more convenient, with less patient side effects. For these reasons, when possible, other medications are or will be reconfigured for home subq infusions.

I believe the company is developing a digital flow monitoring system. It will allow remote monitoring and verification that patients are doing the infusions. I see the system as a important part of the KRMD's partnership with drug companies. Remote monitoring will improve the quality and integrity of the data being collected. When introduced for home infusion will provide a nice revenue stream. LOOK FOR A PATENT HERE!!

blue_skies

05/04/20 3:20 PM

#222 RE: JohnCM #219

I went back and looked at the one year chart. In May of 2019 the stock was trading at $1.60. So there has been a hell of a run. A retrenching is healthy.